SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending amid community discussion about its potential role in the "Golden Dome" defense project, with some anticipating significant contract news. The stock has seen a substantial year-to-date increase, and investors are closely watching for a breakout, particularly in the aerospace and defense sector.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses its recent price action and potential breakout, with focus on fully autonomous testing of Robotaxis in Austin. Bullish sentiment seems to be fueled by upgrades and technical analysis suggesting further upside, while bears cite valuation concerns and potential pullbacks. Community members are actively debating potential price targets, key support levels, and whether the stock is overbought.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to a significant surge in price and trading volume, sparking discussions about a potential short squeeze. Community members are actively debating entry and exit points, with some comparing it to previous high-flying stocks. The company's focus on AI-powered robotics, a sector with growing interest, may also be contributing to the heightened attention.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is gaining traction as community members highlight its strong community, momentum, and potential within the Ethereum ecosystem. Discussions focus on its listing on perpetuals, whale accumulation, and potential as a market hedge, leading to a bullish outlook. The community emphasizes $YEE's unique narrative and connection to Ethereum, drawing comparisons to other successful meme coins.

x402jobs is a platform for creating, running, and monetizing structured automated workflows as pay-per-use APIs using the x402 payment standard. The project allows developers to bundle one or more programmable steps—such as data collection, content generation, analysis, or on-chain interactions—into a single executable “job.” Each job can be triggered manually, on a schedule, via webhook, or by another agent or application. Every execution includes a fixed platform fee and optional pricing set by the job creator. The core purpose of x402jobs is to provide a practical marketplace where software agents and humans can invoke reliable, repeatable automation without subscriptions, long-term contracts, or trust assumptions. Jobs are registered as x402 resources, making them discoverable, composable, and payable using standardized, machine-readable payment rails.

x402jobs

x402jobs ($JOBS) is trending as the community discusses the locking of a significant portion of the token supply. Social media mentions suggest excitement about potential price movement. Chatter also points to the project being a revenue-sharing coin.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim results from its Phase 2b trial, showing promise in brain metastases imaging; the community is actively discussing the potential for a short squeeze and upcoming webinar updates. The stock has seen a massive volume spike, with traders weighing the significance of the trial data and management's presentation for further upside amid volatility.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

Artiva Biotherapeutics is trending after receiving FDA Fast Track designation for AlloNK in refractory rheumatoid arthritis, sparking community discussion about the potential impact on the autoimmune disease treatment landscape. The community is closely watching the stock's higher low structure and catalyst follow-through, while analysts are boosting price targets, citing AlloNK's potential. However, caution is also being urged due to the CEO's share sales and potential offering.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as the stock experiences a significant pullback, sparking debates about its valuation and the sustainability of the AI data center boom. Community discussions revolve around whether the recent drop represents a buying opportunity or reflects deeper concerns about the company's financials and competitive landscape. Bearish sentiment is fueled by concerns of a potential AI bubble and recent market correction.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to renewed enthusiasm in the space sector, spurred by news of a potential SpaceX IPO and discussions around space-based data centers. The community is actively discussing the stock's potential as a competitor in the space industry and the impact of upcoming launches, while also reacting to fluctuations in the stock price and an aborted launch.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors await topline results from its Phase 2b study of Rezpegaldesleukin for alopecia areata, with the community speculating on the potential impact of the data on the company's value. Discussions also revolve around an ongoing lawsuit with Eli Lilly, and whether a settlement or buyout is on the horizon. Bullish sentiment is fueled by analysts setting high price targets, though some caution that a data miss could significantly impact the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks Worth Watching - December 13th

Danaher, Vertex Pharmaceuticals, Moderna, United Therapeutics, argenex, Abivax, and WAVE Life Sciences are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Promising Biotech Stocks To Watch Now - December 14th

Danaher, Vertex Pharmaceuticals, Moderna, United Therapeutics, and argenex are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...

Top Biotech Stocks To Add to Your Watchlist - December 12th

Danaher, Vertex Pharmaceuticals, United Therapeutics, Moderna, Abivax, argenex, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...

Banque Transatlantique SA Cuts Position in Moderna, Inc. $MRNA

Banque Transatlantique SA trimmed its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 73.5% in the second quarter, according to its most recent disclosure with the Securities and...

Bellevue Group AG Has $34.18 Million Stock Position in Moderna, Inc. $MRNA

Bellevue Group AG lessened its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 18.4% in the second quarter, according to its most recent filing with the SEC. The firm owned...

Moderna (NASDAQ:MRNA) Director Sells $13,910.40 in Stock

Moderna, Inc. (NASDAQ:MRNA - Get Free Report) Director Abbas Hussain sold 504 shares of the company's stock in a transaction on Tuesday, December 9th. The shares were sold at an average price of...

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued on behalf...

Moderna (NASDAQ:MRNA) Director Abbas Hussain Sells 504 Shares

Moderna, Inc. (NASDAQ:MRNA - Get Free Report) Director Abbas Hussain sold 504 shares of the firm's stock in a transaction dated Tuesday, December 9th. The shares were sold at an average price of...

Moderna (MRNA) Q4 2024 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Is the Market Bullish or Bearish on Moderna Inc?

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

MRNA
Moderna Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRNA News

MRNAModerna Inc